This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Aptabio Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hyunkyung Yu: Innovator in Pulmonary Fibrosis Medicine
Introduction
Hyunkyung Yu is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of medicine, particularly in the development of treatments for pulmonary fibrosis. His innovative work has led to the creation of a patent that addresses this serious health condition.
Latest Patents
Hyunkyung Yu holds a patent for a "Pulmonary Fibrosis Medicine Containing Pyrazole Derivative." This invention represents a crucial advancement in the treatment options available for patients suffering from pulmonary fibrosis. The patent showcases his commitment to improving healthcare through innovative solutions.
Career Highlights
Throughout his career, Hyunkyung Yu has worked with reputable organizations, including Aptabio Therapeutics Inc. and Mogam Biotechnology Institute. His experience in these companies has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Hyunkyung Yu has collaborated with talented individuals such as Yoo-Kyung Goh and Soo Jin Lee. These partnerships have enhanced his research efforts and have been instrumental in the success of his projects.
Conclusion
Hyunkyung Yu's contributions to the field of medicine, particularly through his patent for pulmonary fibrosis treatment, highlight his role as an innovator. His work continues to inspire advancements in healthcare and offers hope to those affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile